Author:
Tiabi Ikram,Ennaji Youssef,Alaoui Sosse Soukayna,Abumsimir Berjas,Laraqui Abdelilah,Mrabti Mohammed,Benchekroun Mohammed Nabil,Ennaji Moulay Mustapha
Reference36 articles.
1. Abumsimir, B., & Ennaji, M. M. (2019). Suggested parameters to setup Y chromosome microsatellites markers as a prostate cancer genetic risk indicator. Future Oncology, 15(30), 3423–3426.
2. Gynecomammary and Prostate Tumors: Epidemiology and Viral Etiology;Abumsimir,2020
3. Improvement in PET/CT image quality with a combination of point-spread function and time-of-flight in relation to reconstruction parameters;Akamatsu;Journal of Nuclear Medicine,2012
4. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer;Alanee;Familial Cancer,2013
5. Antoni, S., Soerjomataram, I., Møller, B., Bray, F., & Ferlay, J. (2016). An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence. Bulletin of the World Health Organization, 94(3), 174.